Injury of muscle and tendon at neck level

ST19_INJURY_MUSCLE_TENDON_NECK_LEVEL

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — S16 Cause of death: ICD-10 — S16 2 out of 7 registries used, show all original rules.	64
4. Check minimum number of events None	64
5. Include endpoints None	64
6. Filter based on genotype QC (FinnGen only)	64

Control definitions (FinnGen only)

Control exclude: ST19_INJURI_NECK

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: S1
Name in latin: Laesio musculi/tendinis colli

NAME	ST19_INJURY_MUSCLE_TENDON_NECK_LEVEL
CONTROL_EXCLUDE	ST19_INJURI_NECK
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	S16
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	S16
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Injury of muscle and tendon at neck level based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	64	39	25
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	40.86	35.41	49.35

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
55: Matched controls
547

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

S16

ICD-10 Finland

Injury of muscle and tendon at neck level

+∞

78.8

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

27.6

14.8

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

52.8

8.0

W49

ICD-10 Finland

Exposure to other and unspecified inanimate mechanical forces

+∞

6.4

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4010399)

3.82

2.36

1.6

1.1

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

204

2.14

2.28

3.2

9.9

1.2

mmol/l

0.09

176

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2.43

2.27

3.1

3.3

45.5

33.3

ng/l

0.13

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

134

2.12

2.02

1.5

1.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

4.83

1.98

1.4

1.0

—

(42870588) Differential panel, method unspecified - Blood

160

2.05

1.97

5.2

5.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

114

2.10

1.84

1.3

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

173

1.97

1.81

1.6

2.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

513

2.92

1.75

12.3

12.5

40.5

40.6

0.03

412

(3050129) First trimester maternal screen panel - Serum or Plasma

2.51

1.62

1.2

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

2.78

1.56

1.4

1.5

—

(3003694) ABO and Rh group [Type] in Blood

174

1.83

1.48

1.4

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

0.00

1.38

0.0

2.7

—

82.6

—

(40768804) Tissue Pathology biopsy report

189

1.74

1.29

2.1

1.7

—

(3013115) Eosinophils [#/volume] in Blood

267

1.69

1.21

5.2

5.5

0.1

0.2

e9/l

1.81

238

(3019198) Lymphocytes [#/volume] in Blood

267

1.69

1.21

5.2

4.8

1.8

2.1

e9/l

0.56

238

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

489

1.89

1.06

11.3

10.3

94.6

90.8

ml/min/173m2

0.64

386

(3020682) Albumin/Creatinine [Ratio] in Urine

118

1.73

1.06

3.6

4.0

2.9

16.9

mg/mmol

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

0.00

1.00

0.0

2.2

—

1.6

—

(3006315) Basophils [#/volume] in Blood

257

1.59

0.99

5.3

4.8

0.0

e9/l

0.02

228

(3012516) Albumin [Mass/volume] in Urine

112

1.71

0.98

2.9

3.2

27.8

138.0

mg/l

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

2.00

0.97

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

2.00

0.97

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

2.00

0.97

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

2.00

0.97

1.3

1.4

—

(3001604) Monocytes [#/volume] in Blood

258

1.58

0.97

5.3

4.7

0.6

e9/l

0.27

228

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2.26

0.94

2.3

2.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.26

0.94

1.0

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

444

1.73

0.94

4.0

3.7

—

(3000850) Epithelial cells [#/volume] in Urine

1.69

0.88

3.5

2.2

8.5

4.3

e6/l

0.55

(3037467) Urinalysis macro (dipstick) panel - Urine

365

1.54

0.82

4.3

3.8

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.81

0.0

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

484

1.74

0.81

3.9

3.8

5.7

mmol/l

0.11

452

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

0.00

0.79

0.0

2.2

—

0.8

—

(3003338) MCHC [Mass/volume]

485

1.73

0.79

13.3

14.4

334.1

333.8

g/l

0.07

480

(3032080) INR in Blood by Coagulation assay

155

1.53

0.76

4.4

8.1

1.0

1.2

inr

—

(3013512) EKG study

111

1.59

0.75

2.8

3.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.84

0.74

1.3

1.6

—

(3042936) Bacteria identified in Isolate by Culture

1.76

0.73

1.4

2.9

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

157

1.50

0.72

3.6

2.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

540

1.79

0.69

10.9

11.8

14.5

19.4

mg/l

0.92

412

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

140

1.51

0.69

1.6

2.4

—

(3023368) Bacteria identified in Blood by Culture

114

1.54

0.67

2.5

4.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

245

1.42

0.64

3.4

4.7

—

(3009508) Creatinine [Moles/volume] in Urine

142

1.48

0.64

2.9

10.6

8.3

mmol/l

0.70

127

(3002256) Pathology report gross observation

1.65

0.63

1.3

1.2

—

(3019225) pH of Specimen

1.79

0.59

1.7

6.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

0.00

0.59

0.0

1.3

—

(3020891) Body temperature

0.00

0.59

0.0

2.7

—

(36304419) Bacteria [Presence] in Urine

136

1.45

0.57

2.6

2.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.52

0.56

2.7

2.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

155

1.42

0.56

3.4

2.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1.64

0.56

16.2

12.9

—

1.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

301

1.36

0.52

6.0

7.5

3.9

e9/l

0.00

266

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

0.59

0.49

1.6

1.7

—

(3022145) Colonoscopy Study observation

1.45

0.47

2.0

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.61

0.46

1.3

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

160

1.36

0.46

3.5

3.6

11.8

20.1

ng/l

—

(3022621) pH of Urine by Test strip

1.56

0.42

1.8

1.9

—

(3037121) Protein [Mass/volume] in Urine

0.00

0.42

0.0

2.9

—

0.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.42

0.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.42

0.0

1.1

—

(4034850)

0.00

0.41

0.0

6.9

—

(3008898) HLA-B27 [Presence]

1.51

0.41

1.2

1.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.00

0.40

0.0

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.00

0.40

0.0

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.00

0.40

0.0

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.38

0.40

1.2

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

519

1.42

0.40

4.3

3.9

2.7

2.8

mmol/l

0.19

486

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

121

0.70

0.40

1.1

2.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

165

0.73

0.38

2.1

1.8

90.3

91.7

pmol/l

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

203

1.29

0.37

4.0

3.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.47

0.37

1.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

0.67

0.36

1.2

1.9

0.6

1.3

—

(40761536) Microorganisms panel - Urine sediment

1.40

0.35

3.0

3.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.39

0.35

1.5

1.6

—

(3044889) 12 lead EKG panel

323

1.26

0.34

3.1

3.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.34

0.34

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

151

0.75

0.33

1.4

1.6

—

(36660697) Celiac disease serology panel - Serum

1.33

0.32

1.0

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.31

0.31

1.3

1.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1.31

0.31

1.1

2.7

20.3

26.8

—

(3021589) Normoblasts [#/volume] in Blood

243

0.80

0.30

8.7

7.9

0.0

e9/l

0.00

198

(40760892) CBC W Ordered Manual Differential panel - Blood

113

1.31

0.30

4.1

3.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

113

1.31

0.30

2.9

3.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

513

1.34

0.29

3.8

3.5

1.5

1.4

mmol/l

0.36

479

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.23

0.26

2.3

1.7

—

(3009261) Glucose [Presence] in Urine by Test strip

262

1.20

0.23

4.1

3.1

0.0

estimate

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

127

1.24

0.22

1.7

2.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1.21

0.22

4.2

2.4

1.6

1.7

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.21

0.0

3.5

—

18.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.21

0.0

2.4

—

56.9

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.21

0.0

2.4

—

4.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.21

0.0

3.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

(1616796) Gas panel - Central venous blood

0.00

0.21

0.0

3.5

—

(3022313) Gas panel - Capillary blood

0.00

0.20

0.0

5.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.20

0.0

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.17

0.19

2.7

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

129

1.21

0.19

1.7

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.21

0.19

1.1

2.6

2.4

g/l

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.71

0.18

1.2

1.5

—

(21494755) Public health laboratory ask at order entry panel

1.20

0.16

1.0

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

260

1.14

0.14

4.0

3.0

0.0

estimate

—

(3044640) Blood type and Crossmatch panel - Blood

155

0.88

0.10

1.7

2.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1.15

0.10

1.6

4.0

219.0

223.9

u/l

—

(3000492) Spirometry study

1.10

0.09

1.7

1.3

—

(40768797) Stomach Pathology biopsy report

1.04

0.08

1.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1.12

0.08

1.1

2.7

13.1

15.2

umol/l

—

(1761868) Lipid panel - Serum or Plasma

196

1.11

0.08

2.5

—

(40758558) Short blood count panel - Blood

132

0.89

0.07

3.8

6.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

0.84

0.07

3.8

3.6

669.0

780.8

ng/l

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

178

1.10

0.06

4.8

5.4

38.4

36.8

g/l

0.73

171

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

499

1.11

0.06

3.5

3.3

1.2

mmol/l

0.12

462

(3029937) Albumin [Presence] in Urine by Test strip

139

1.10

0.06

5.3

3.3

0.0

estimate

—

(3026008) Bacteria identified in Urine by Culture

141

1.08

0.04

3.3

2.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

112

1.09

0.03

2.9

2.6

24434.8

341.7

umol/l

0.47

100

(3002385) Erythrocyte distribution width [Ratio]

482

1.07

0.02

15.0

13.9

13.2

13.5

1.34

476

(3015736) pH of Urine

206

0.96

0.00

4.4

2.8

—

(3000494) Fungus identified in Specimen by Culture

0.88

0.00

1.0

1.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

2.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.0

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.0

2.4

—

3.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.5

—

(3028271) Lactate [Moles/volume] in Capillary blood

0.00

0.0

2.0

—

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

0.96

0.00

2.6

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.0

4.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

0.00

0.0

1.6

—

451.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

0.0

2.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

4.6

—

33.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.6

—

106.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

0.00

0.0

1.6

—

0.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

0.0

1.7

—

(3021901) Oxygen saturation in Capillary blood

0.00

0.0

3.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

0.00

0.0

1.3

—

12.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.00

0.0

1.2

—

6.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1.02

0.00

2.3

4.0

0.8

mmol/l

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.0

1.0

—

33.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

0.0

2.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

0.00

0.0

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.0

20.2

—

1255.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(40768806) Pleura Pathology biopsy report

0.00

0.0

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

0.0

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3011648) Oxygen content in Venous blood

0.00

0.0

3.4

—

11.6

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

0.0

4.2

—

4.8

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

0.00

0.0

3.9

—

0.6

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

0.0

1.3

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

0.0

4.2

—

8.0

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

0.0

1.0

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

0.0

1.7

—

88.8

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

0.0

1.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

0.00

0.0

2.7

—

8.5

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.0

2.9

—

71.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

0.0

1.8

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

8.2

—

802.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

0.0

1.5

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.0

2.4

—

107.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.2

—

(3024928) Oxygen saturation in Venous blood

0.00

0.0

6.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_INJURY_MUSCLE_TENDON_NECK_LEVEL – Injury of muscle and tendon at neck level

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Injury of muscle and tendon at neck level

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Injury of muscle and tendon at neck level (ST19_INJURY_MUSCLE_TENDON_NECK_LEVEL)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints